Cyclodextrin complexes of valdecoxib: Properties and anti-inflammatory activity in rat

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 60, Issue 1, 2005, Pages 39-46

  Rajendrakumar, Kale ^a   Madhusudan, Saraf ^a   Pralhad, Tayade ^b  

^a BOMBAY COLLEGE OF PHARMACY   (India)

^b INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

Author keywords

Anti inflammatory activity; Cyclodextrin complexation; Modified cyclodextrins; Valdecoxib

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; 7 BETA CYCLODEXTRIN SULFOBUTYL ETHER; ANTIINFLAMMATORY AGENT; BETA CYCLODEXTRIN DERIVATIVE; CARBOXYMETHYLCELLULOSE; UNCLASSIFIED DRUG; VALDECOXIB; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CIRCULAR DICHROISM; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG SOLUBILITY; DRUG SYNTHESIS; EVAPORATION; HYDROPHILICITY; INFRARED SPECTROSCOPY; LIQUID; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; RAT; SOLID; X RAY DIFFRACTION;

EID: 17444420664     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2004.12.005     Document Type: Article

References (17)

1. Physicians Desk Reference, 57th ed., Medical Economics Company, Inc. NJ, 2003. p. 2577.
2. T. Loftsson, and M. Brewster Pharmaceutical application of cyclodextrins. I. Drug solubilization and stabilization J. Pharm. Sci. 85 1996 1017 1025
3. R.A. Rajewski, and V.J. Stella Pharmaceutical application of cyclodextrins. II. In vivo drug delivery J. Pharm. Sci. 85 1996 1142 1169
4. K.H. Fromming, and J. Szejtli Cyclodextrins in Pharmacy 1994 Kluwer Academic Publishers Dordrecht
5. K. Uekama, F. Hirayama, and I. Tetsumi Cyclodextrin drug carrier systems Chem. Rev. 98 1998 2045 2076
6. G.P. Bettinetti, A. Gazzaniga, P. Mura, F. Giordano, and M. Setti Thermal behavior and dissolution properties of Naproxen in combinations with chemically modified β-cyclodextrins Drug Dev. Ind. Pharm. 18 1992 39 53
7. K.A. Khan The concept of dissolution efficiency J. Pharm. Pharmacol. 27 1975 48 49
8. C.A. Wintar, E.A. Risley, and G.W. Nuss Carrageenan induced edema in hind paw of the rat as an assay for anti-inflammatory drugs Proc. Soc. Exp. Biol. Med. 111 1962 544 546
9. K.H. Kim, M.J. Frank, and N.L. Henderson Applications of differential scanning calorimetry to the study of solid drug dispersions J. Pharm. Sci. 74 1985 283 289
10. L.J. Bellamy The Infra-Red spectra of Complex Molecules 1958 Wiley New York p. 166
11. Y. Nakai, K. Yamamoto, K. Tereda, and H. Honbe Interaction of tri-O-methyl-β-cyclodextrin with drug J. Incl. Phenom. 2 1984 523 531
12. P. Mura, N. Zerrouk, M.T. Faucci, F. Maestrelli, and C. Chemtob Comparative study of ibuproxam complexation with amorphous β-cyclodextrin derivatives in solution and in the solid state Eur. J. Pharm. Biopharm. 54 2002 181 191
13. P. Mura, G.P. Bettinetti, A. Manderioli, M.T. Faucci, G. Bramanti, and M. Sorrenti Interactions of ketoprofen and ibuprofen with β-cyclodextrins in solution and in the solid state Int. J. Pharm. 166 1998 189 203
14. K. Ikeda, K. Uekama, and M. Otagiri Inclusion complexes of β-cyclodextrin with antiinflammatory drugs fenamates in aqueous solution Chem. Pharm. Bull. 23 1975 201 208
15. O.I. Corrigan, and T. Stanley Mechanism of drug dissolution enhancement from β-cyclodextrin-drug systems J. Pharm. Pharmacol. 34 1982 621 626
16. F.J. Otero-Espinar, S. Anguiano-Igea, N.G. Gonzalez, J.L. Vila-Jato, and J. Blanco-Mendez Oral bioavailability of naproxen-β-cyclodextrin inclusion compound Int. J. Pharm. 75 1991 37 44
17. J. Szejtli Controlled Drug Bioavailability 1985 Wiley New York